A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity
Open Access
Abstract
Malaria is caused by eukaryotic protozoan parasites of the genus Plasmodium. There are 249 million new cases and 608,000 deaths annually, and new interventions are desperately needed. Malaria vaccines can be divided into three categories: liver stage, blood stage, or transmission-blocking vaccines. Transmission-blocking vaccines prevent the transmission of disease by the mosquito vector from one human to another. Pfs230 is one of the leading transmission-blocking vaccine antigens for malaria. Here, we describe the development of a 24-copy self-assembling nanoparticle vaccine comprising domain 1 of Pfs230 genetically fused to H. pylori ferritin. The single-component Pfs230D1-ferritin construct forms a stable and homogenous 24-copy nanoparticle with good production yields. The nanoparticle is highly immunogenic, as two low-dose vaccinations of New Zealand White rabbits elicited a potent and durable antibody response with high transmission-reducing activity when formulated in two distinct adjuvants suitable for translation to human use. This single-component 24-copy Pfs230D1-ferritin nanoparticle vaccine has the potential to improve production pipelines and the cost of manufacturing a potent and durable transmission-blocking vaccine for malaria control.Keywords
Funding Information
- Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
This publication has 94 references indexed in Scilit:
- A conserved N protein nano‐vaccine of COVID‐19 exerts potent and cross‐reactive humoral and cellular immune responses in miceJournal of Medical Virology, 2023
- Bacterioferritin nanocage: Structure, biological function, catalytic mechanism, self-assembly and potential applicationsBiotechnology Advances, 2022
- mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceCell Reports, 2022
- Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenzaJournal of Leukocyte Biology, 2022
- SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityCell Reports, 2021
- Structure‐based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeaeFEBS Open Bio, 2017
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteCell, 2015
- High-Throughput SAXS for the Characterization of Biomolecules in Solution: A Practical Approach2013
- Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230Molecular and Biochemical Parasitology, 1993
- Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230Molecular and Biochemical Parasitology, 1993